These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 27800663)
1. Advances in the development of aptamer drug conjugates for targeted drug delivery. Chen K; Liu B; Yu B; Zhong W; Lu Y; Zhang J; Liao J; Liu J; Pu Y; Qiu L; Zhang L; Liu H; Tan W Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 May; 9(3):. PubMed ID: 27800663 [TBL] [Abstract][Full Text] [Related]
2. A basic insight into aptamer-drug conjugates (ApDCs). Xuan W; Peng Y; Deng Z; Peng T; Kuai H; Li Y; He J; Jin C; Liu Y; Wang R; Tan W Biomaterials; 2018 Nov; 182():216-226. PubMed ID: 30138784 [TBL] [Abstract][Full Text] [Related]
4. Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery. Liao J; Liu B; Liu J; Zhang J; Chen K; Liu H Expert Opin Drug Deliv; 2015 Mar; 12(3):493-506. PubMed ID: 25430795 [TBL] [Abstract][Full Text] [Related]
5. Aptamer-Based Targeted Drug Delivery Systems: Current Potential and Challenges. He F; Wen N; Xiao D; Yan J; Xiong H; Cai S; Liu Z; Liu Y Curr Med Chem; 2020; 27(13):2189-2219. PubMed ID: 30295183 [TBL] [Abstract][Full Text] [Related]
6. Advances in aptamer-mediated targeted delivery system for cancer treatment. He S; Du Y; Tao H; Duan H Int J Biol Macromol; 2023 May; 238():124173. PubMed ID: 36965552 [TBL] [Abstract][Full Text] [Related]
7. Molecular aptamers for drug delivery. Tan W; Wang H; Chen Y; Zhang X; Zhu H; Yang C; Yang R; Liu C Trends Biotechnol; 2011 Dec; 29(12):634-40. PubMed ID: 21821299 [TBL] [Abstract][Full Text] [Related]
8. Nucleic acid aptamers: an emerging frontier in cancer therapy. Zhu G; Ye M; Donovan MJ; Song E; Zhao Z; Tan W Chem Commun (Camb); 2012 Nov; 48(85):10472-80. PubMed ID: 22951893 [TBL] [Abstract][Full Text] [Related]
9. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy. Li X; Zhao Q; Qiu L J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885 [TBL] [Abstract][Full Text] [Related]
10. Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications. Guan B; Zhang X Int J Nanomedicine; 2020; 15():1059-1071. PubMed ID: 32110008 [TBL] [Abstract][Full Text] [Related]
11. [Advances in the study of aptamer-based drug for targeting therapy]. Dou XQ; Fu J; Song HF Yao Xue Xue Bao; 2016 Jul; 51(7):1068-76. PubMed ID: 29897179 [TBL] [Abstract][Full Text] [Related]
12. Aptamer-functionalized liposomes for drug delivery. Wong KY; Wong MS; Liu J Biomed J; 2024 Aug; 47(4):100685. PubMed ID: 38081386 [TBL] [Abstract][Full Text] [Related]
13. Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents. Kim M; Kim DM; Kim KS; Jung W; Kim DE Molecules; 2018 Apr; 23(4):. PubMed ID: 29617327 [TBL] [Abstract][Full Text] [Related]
14. Aptamer-Mediated Polymeric Vehicles for Enhanced Cell-Targeted Drug Delivery. Tan KX; Danquah MK; Sidhu A; Yon LS; Ongkudon CM Curr Drug Targets; 2018 Feb; 19(3):248-258. PubMed ID: 27321771 [TBL] [Abstract][Full Text] [Related]
15. Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications. Ni S; Zhuo Z; Pan Y; Yu Y; Li F; Liu J; Wang L; Wu X; Li D; Wan Y; Zhang L; Yang Z; Zhang BT; Lu A; Zhang G ACS Appl Mater Interfaces; 2021 Mar; 13(8):9500-9519. PubMed ID: 32603135 [TBL] [Abstract][Full Text] [Related]
17. Tumor-targeted drug delivery with aptamers. Zhang Y; Hong H; Cai W Curr Med Chem; 2011; 18(27):4185-94. PubMed ID: 21838687 [TBL] [Abstract][Full Text] [Related]
18. Aptamer as a targeted approach towards treatment of breast cancer. Bisht A; Bhowmik S; Patel P; Gupta GD; Kurmi BD J Drug Target; 2024 Jun; 32(5):510-528. PubMed ID: 38512151 [TBL] [Abstract][Full Text] [Related]
19. Aptamers used for biosensors and targeted therapy. Ning Y; Hu J; Lu F Biomed Pharmacother; 2020 Dec; 132():110902. PubMed ID: 33096353 [TBL] [Abstract][Full Text] [Related]
20. Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity. Dou XQ; Wang H; Zhang J; Wang F; Xu GL; Xu CC; Xu HH; Xiang SS; Fu J; Song HF Int J Nanomedicine; 2018; 13():763-776. PubMed ID: 29440899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]